JCR Pharmaceuticals to Present at the American Society of Gene and Cell Therapy 28th Annual Meeting
PRESS RELEASE: Paid Content from Business Wire. The AP news staff was not involved in its creation.
Published [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year]
HYOGO, Japan--(BUSINESS WIRE)--May 8, 2025--
JCR Pharmaceuticals Co., Ltd. (TSE 4552; 'JCR') announced today that it will present updated preclinical data from its proprietary J-Brain Cargo ® -applied adeno-associated virus (AAV) vector gene therapy non-clinical research programs in an oral abstract session at the American Society of Gene and Cell Therapy (ASGCT) 28 th Annual Meeting, being held May 13-17, 2025, in New Orleans, LA.
The oral presentation details are listed below, and the full program can be found on the ASGCT congress website at https://annualmeeting.asgct.org/ .
Title: Incorporation of transferrin receptor binder and surface mutations into AAV enables efficient brain delivery and reduced liver tropism
Session: AAV Gene Transfer (A): Crossing the Blood-Brain Barrier
Abstract Number: 92
Date/Time: Wednesday, May 14, 2:30-2:45pm CT
Presenter: Yuhei Ashida, Associate Senior Scientist, at JCR Pharmaceuticals
About the American Society of Gene and Cell Therapy (ASGCT) The American Society of Gene and Cell Therapy (ASGCT) is the primary professional membership organization for gene and cell therapy. The Society's members are scientists, physicians, patient advocates, and other professionals. The mission of the ASGCT is to advance knowledge, awareness, and education, leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease. For more information, please visit www .asgct.org .
About the J-Brain Cargo ® Platform Technology JCR Pharmaceuticals has developed a proprietary blood-brain barrier (BBB)-penetrating technology, J-Brain Cargo ®, to bring biotherapeutics into the central nervous system (CNS). The first drug developed based on this technology is IZCARGO ® (INN: pabinafusp alfa) and was approved in Japan for the treatment of a lysosomal storage disorder.
About JCR Pharmaceuticals Co., Ltd. JCR Pharmaceuticals Co., Ltd. (TSE 4552) is a global specialty pharmaceuticals company that is expanding possibilities for people with rare and genetic diseases worldwide. We continue to build upon our 50-year legacy in Japan while expanding our global footprint into the US, Europe, and Latin America. We improve patients' lives by applying our scientific expertise and unique technologies to research, develop, and deliver next-generation therapies. Our approved products in Japan include therapies for the treatment of growth disorder, MPS II (Hunter syndrome), Fabry disease, acute graft-versus host disease, and renal anemia. Our investigational products in development worldwide are aimed at treating rare diseases including MPS I (Hurler, Hurler- Scheie and Scheie syndrome), MPS II, MPS IIIA and B (Sanfilippo syndrome type A and B), and more. JCR strives to expand the possibilities for patients while accelerating medical advancement at a global level. Our core values – reliability, confidence, and persistence – benefit all our stakeholders, including employees, partners, and patients. For more information, please visit https://www.jcrpharm.co.jp/en/site/en/ .
View source version on businesswire.com: https://www.businesswire.com/news/home/20250508730248/en/
CONTACT: Investors & Media:
JCR Pharmaceuticals Co., Ltd.
Corporate Communications
[email protected]
KEYWORD: UNITED STATES JAPAN NORTH AMERICA ASIA PACIFIC LOUISIANA
INDUSTRY KEYWORD: SCIENCE NEUROLOGY OTHER SCIENCE RESEARCH PHARMACEUTICAL GENERAL HEALTH HEALTH GENETICS
SOURCE: JCR Pharmaceuticals Co., Ltd.
Copyright Business Wire 2025.
PUB: 05/08/2025 12:05 PM/DISC: 05/08/2025 12:06 PM
http://www.businesswire.com/news/home/20250508730248/en
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Gizmodo
5 hours ago
- Gizmodo
‘GQuuuuuuX' Is Taking Its ‘Gundam' Remix to a Whole Other Level
Last week, I said that Mobile Suit Gundam GQuuuuuuX's remixing of the original Gundam continuity was letting several of the original series' biggest characters haunt the narrative, from the absent Amuro Ray, to the slightly less absent Char Aznable, and then the one figure who's really been skirting around the edges of GQuuuuuuX's periphery in earnest, the mysterious Lalah Sune. This week, Lalah stopped skirting… and then some. To the surprise of no one after last week's setup, episode nine of GQuuuuuuX, 'The Rose of Sharon,' is indeed for the most part about Lalah Sune making her way into the series' narrative, as Machu manages to escape confinement with the GQuuuuuuX and head to Earth, where she finds Lalah forced to work at a lavish brothel. But while this Lalah is indeed a Newtype—regaling staff and Machu alike of the visions she sees in her dreams—she is not the Rose of Sharon that Machu was seeking in her hopes to be reunited with Shuji. Instead, this Lalah is almost haunted by what has come to pass, her Newtypism not really granting her a vision of the future, but what was, as GQuuuuuuX offers yet another spin on a classic scene from the 1979 anime. Floating in the cosmic glow that represents the connection forged between Newtypes, Lalah flatly explains that the future she sees is her own: the future of another Lalah, a young woman who meets a young Zeon officer in red who whisks her to the stars… a Lalah who falls in love with that man, and also his rival, as she dies in battle saving the former from the latter. What the Lalah of GQuuuuuuX sees beyond time, as she says to Machu, is the original story of Mobile Suit Gundam. The implication then that GQuuuuuuX's remixed timeline of the Universal Century co-exists alongside Gundam's original one, in some capacity, already raises a bunch of fascinating questions, but things only get more interesting in the episode's climactic moments, when we and Machu alike discover that the Lalah was right when she told them that she is not the rose neither she, nor Shuji, nor everyone else has been looking for after it went missing… Because another Lalah Sune is. The Lalah Sune, if you will. Hidden for years at the bottom of the ocean until Machu and the GQuuuuuuX find it, Lalah's mobile armor the Elmeth, locked in time from the moment of her death in the 1979 anime, has some how become an almighty object of vast psionic power, a Newtype beacon that has transitioned across this divergent timeline, calling out to the generation of Newtypes that forged it in the first place in characters like Char and Lalah, but also the generation that has grown beyond them in this new timeline, like Machu, Nyaan, and Shuji. Of course, Gundam is no stranger to the alternate reality trend that has become du jour in contemporary pop culture. It's been on it for decades at this point, when Mobile Fighter G Gundam created the first alternate Gundam universe to exist on TV outside of the stories that had been told in the Universal Century setting. Ever since we've had a bunch of other alternate realities to provide the setting to new Gundam series, we've had realities that, like GQuuuuuuX, has mirrored and riffed on the Universal Century stories to create their own echoes of its ideas. Hell, Turn A Gundam presented a vision where its setting was a far-flung future after a 'Dark History' that eradicated humanity back to a technological reset—one that touched upon every corner of Gundam continuity up to that point in some way, a comment on the cyclical nature of historical trends, while also symbolically honoring the entire metatext of the franchise up to that point, regardless of continuity. Suffice to say, the coexistence of a GQuuuuuuX timeline, with all its changes, and that potential of the original timeline alongside it, is not exactly unfamiliar territory that Gundam is wading into as it explores all this. With GQuuuuuuX having just a few more episodes to lay out what exactly it wants to say in all this remixing and meta-commentary, time will tell if all these self-referential reveals will result in the series creating something additive to that vast canon—or if its wild evocations are simply designed to spin the heads of diehard fans.
Hypebeast
6 hours ago
- Hypebeast
Madhappy Opens First New York City Flagship
Summary It's hard to believeMadhappyhasn't had a full-time outpost in New York City – until now. Marking the brand's second flagship in the US and first permanent brick-and-mortar store in NYC, the mental health-inspired outfitter has opened its doors to its new Downtown Manhattan home. Housed in the heart of Soho on Mulberry Street, the new Madhappy storefront was brought to life, once again, with the help of Los Angeles-based PlayLab, Inc., the creative studio also behind the brand's first-ever full-time flagship store in Los Angeles. The two-story outpost leans into the brand's signature blue-dyed concrete, complemented by brushed aluminum, ceramic tile, and Douglas fir detailing. Inside the store, Madhappy opens another 'Pantry,' – the brand's own café concept that debuted in West Hollywood – with a selection of local and global culinary partners, including Japan-based HOTEL DRUGS and local eateries Sofreh and Tom's Juice. Additionally, the store serves as the home to a handful of New York City-inspired collaborative capsules, including releases with the New York Yankees, the New York Mets, and Lucali Pizza. Take a closer look inside the store in the gallery above, and pop by the Madhappy New York City store at the address below. 207 Mulberry StreetNew York, New York, 10012Monday through Friday: 11 a.m. – 6 11 a.m. – 5 p.m.
Forbes
8 hours ago
- Forbes
Japan Is About To Land On The Moon — Here's How To Watch It Live
Tokyo, Japan-based ispace will make its second attempt to land its 'Resilience' lunar lander on the moon's near side on Thursday, June 5, 2025, just two years after its failed first attempt. The lunar lander, called 'Resilience,' will attempt to land on the moon at 3:24 p.m. EDT on Thursday, June 5. The event will be live-streamed on the ispace website and on YouTube, with live coverage beginning at 2:10 p.m. EDT. The spacecraft will attempt to land in Mare Frigoris ('Sea of Cold'), a a long and thin lunar lunar mare in the far north of the moon's Northern Hemisphere. A mare on the moon is a dark plain formed by lava flowing into basins formed by meteor impacts. The landing window is open from June 6 through June 8, 2025, so it's possible that the exact time of touchdown will change. According to ispace, there are also three backup landing sites. The attempt is part of a mission called ispace SMBC x Hakuto-R Venture Moon. It will have taken the spacecraft 141 days to reach the moon since it was launched atop a SpaceX Falcon 9 rocket on January 15, 2025. If a safe landing is executed, a small rover called 'Tenacious' will conduct a technology demonstration, attempting to use a small shovel to extract regolith — dust and broken rocks on the surface of the moon — while moving around on the lunar surface. It will send data back to the lander as well as images from its high-definition camera. Also on board 'Resilience' are water electrolyzer equipment, a food production experiment, a deep space radiation probe, a commemorative alloy plate, and a model house by Swedish artist Mikael Genberg dubbed the 'Moonhouse.' During its first attempt to land on the moon on April 25, 2023, ispace lost contact with its Hakuto-R lander, suggesting a crash landing. On January 19, 2024, the Japan Aerospace Exploration Agency's Smart Lander for Investigating Moon — dubbed SLIM — made a precision landing, albeit landing upside-down. That made Japan the fifth country to make a soft landing on the moon after the Soviet Union (now Russia), the U.S., China and India. ispace is describes itself as a global lunar exploration company, which plans to create frequent, low-cost "moon shuttle" transportation to the lunar surface, specifically for mining companies. It has further missions to fly alternative landers scheduled for 2026 and 2027. On June 3, 2025, ispace announced that it had signed a contract worth around $2.9 million with the European Space Agency to launch a rover called MAGPIE.
